Class-Action Suit Accuses Walmart, Drugmakers of Selling Contaminated Irbesartan

Drug Industry Daily
A A
A Florida class-action suit charges Walmart, Aurobindo Pharma, ScieGen Pharmaceuticals and Westminster Pharmaceuticals negligently allowed potentially carcinogenic blood pressure drugs onto the market.

To View This Article:

Login

Subscribe To Drug Industry Daily